DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Brain

Brain Differences May Impact Ability to Recognize Low Blood Sugar

Healthy adults can typically recognize when their blood sugar may be becoming too low. It triggers physical symptoms such as dizziness, sweating, weakness, and rapid heartbeat, just to name a few. Plus, their body responds by producing glucose and initiating the brain to signal for food. However, in individuals with type 1 diabetes, the brain does not always respond in this way.

A recent study found that the areas of the brain activated by low blood sugar in adults without diabetes are not the same as those in adults with type 1 diabetes. In brain scans of non-diabetic adults, areas associated with reward, motivation, and decision making showed changes during brain scans. However, only half of the individuals with T1D experienced similar changes, and only in one area of the brain – the area associated with attention – and the other half experienced no changes. Their brain showed no noticeable response to having low blood sugar, which is why individuals may miss cues that others would typically pick up on.

According to Janice Hwang, M.D., assistant professor of medicine and first author on the study, “There is a progressive loss of coordinated brain response to low blood sugar as you go from healthy adult to aware to unaware. The first areas of the brain to go are associated with feeding behavior.” The researchers are hoping that these findings will lead to more effective ways of restoring low blood sugar awareness in individuals with T1D who have lost this awareness.

It is these types of discoveries that help to improve understanding of how T1D affects the brain and body and allows researchers to develop more effective ways of treating and managing the condition. The Diabetes Research Connection supports early career scientists striving to advance research regarding the treatment, prevention, diagnosis, and management of T1D. Researchers can receive up to $50,000 in funding to apply toward their project. Click to learn more about current projects and provide support.

Learn More +

OUR PROJECTS

See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
zhang
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Melanie
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha